PHIBRO ANIMAL HEALTH CORP·4

Jun 2, 6:56 PM ET

CORCORAN E THOMAS 4

4 · PHIBRO ANIMAL HEALTH CORP · Filed Jun 2, 2026

Research Summary

AI-generated summary of this filing

Updated

Phibro (PAHC) Director Corcoran Thomas Buys 10,000 Shares

What Happened
Corcoran E. Thomas, a director of Phibro Animal Health Corp. (PAHC), made an open-market purchase of 10,000 shares on 2026-05-29 at a weighted average price of $31.77 per share, for a total of approximately $317,700. This transaction is coded as a purchase (P), which is typically viewed as a direct acquisition of company stock.

Key Details

  • Transaction date: 2026-05-29 (filed with the SEC on 2026-06-02; appears to meet the 2-business-day Form 4 filing deadline).
  • Price: weighted average $31.77; individual trades ranged from $31.66 to $31.85 (footnote F1). The reporting person can provide a breakdown of amounts at each price on request.
  • Shares purchased: 10,000; total value ≈ $317,700.
  • Shares owned after the transaction: not specified in the provided filing.
  • Additional note: filing states it "Includes 1,459 shares acquired under a dividend reinvestment plan sponsored by the Reporting Person's broker" (footnote F2) — this pertains to the ownership reported in the filing.
  • Transaction code: P = Purchase (open market).

Context
This was an outright open-market purchase (not an option exercise, gift, or grant). Purchases by insiders can be taken as a signal of personal investment but do not by themselves prove future company performance. The filing includes a weighted-average price disclosure and a promise to provide per-trade pricing detail on request.

Insider Transaction Report

Form 4
Period: 2026-05-29
Transactions
  • Purchase

    Class A Common Stock

    [F1][F2]
    2026-05-29$31.77/sh+10,000$317,70041,459 total
Footnotes (2)
  • [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $31.66 to $31.85. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range.
  • [F2]Includes 1,459 shares acquired under a dividend reinvestment plan sponsored by the Reporting Person's broker.
Signature
/s/ Judith Weinstein, as Attorney-in-Fact for E. Thomas Corcoran|2026-06-02

Documents

1 file
  • 4
    tm2616591-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT